Andy G. Chen, PhD Cfa
About Andy G. Chen, PhD Cfa
Andy G. Chen, PhD, CFA, is a Senior Associate at Berenberg Capital Markets, specializing in biotech and pharma investments. He has extensive experience in equity research and management consulting, with a strong academic background from Yale University and Cornell University.
Work at Berenberg
Andy G. Chen serves as a Senior Associate at Berenberg Capital Markets, a position he has held since 2023. In this role, he is part of a highly regarded equity research team that has achieved a #1 ranking. His responsibilities include conducting in-depth analysis and providing insights on investment opportunities within the biotech and pharmaceutical sectors.
Previous Experience in Investments
Prior to his current role, Chen worked at Roivant Sciences as an Associate in Investments from 2020 to 2022. During his tenure in New York, he focused on both public and private biotech and pharmaceutical investments, gaining extensive experience in the investment landscape. Before Roivant, he held the position of Assistant Vice President in Equity Research at AB Bernstein from 2018 to 2020.
Consulting Background
Chen's career includes a significant period at The Dedham Group, where he served as a Consultant in Management Consulting from 2015 to 2018. This role allowed him to develop skills in strategic analysis and client engagement, further enhancing his expertise in the financial sector.
Education and Expertise
Chen holds a Doctor of Philosophy (Ph.D.) in Molecular Biology from Yale University, which he completed from 2009 to 2014. He also earned a Bachelor of Arts in Genetics and Development from Cornell University between 2005 and 2009. Additionally, he has been a CFA charterholder since 2018, underscoring his proficiency in financial analysis and investment management.